The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

Researchers found weight returns far faster after stopping GLP-1 drugs than after diet or exercise programmes On average, ...

Jelly Roll's wife Bunnie Xo said she's watching the country singer "fall in love with himself" again after losing 200 pounds ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults ...